Abbas Lugemwa

1.3k citations
5 papers · 69 indexed · h-index 4
Topics
HIV Research and Treatment (3 papers)HIV/AIDS drug development and treatment (3 papers)Pneumocystis jirovecii pneumonia detection and treatment (2 papers)

In The Last Decade

Abbas Lugemwa

5 papers receiving 69 citations

Peers

Abbas Lugemwa
Comparison fields: 5 of 27
  • Infectious Diseases 42
  • Virology 32
  • Pediatrics, Perinatology and Child Health 18
  • Emergency Medicine 14
  • Neurology 11
Replace Godfrey Musoro with:
Godfrey Musoro Zimbabwe
Hellen Musana Uganda
Wendy Beadles United Kingdom
Kiana Keller United States
Shafic Makumbi Zimbabwe
Joel Singer Canada
Maximilian Münchhoff Germany
Pascale Perfezou France
Ann Sarah Walker United Kingdom
Anton Pozniak United Kingdom
Abbas Lugemwa relative to Godfrey Musoro Zimbabwe Godfrey Musoro's profile →
Citations per field
00.5×1.5×
Godfrey Musoro · 1×
Citations per year

Countries citing papers authored by Abbas Lugemwa

Since Specialization
Citations

This map shows the geographic impact of Abbas Lugemwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abbas Lugemwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abbas Lugemwa more than expected).

Fields of papers citing papers by Abbas Lugemwa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abbas Lugemwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abbas Lugemwa. The network helps show where Abbas Lugemwa may publish in the future.

Co-authorship network of co-authors of Abbas Lugemwa

This figure shows the co-authorship network connecting the top 25 collaborators of Abbas Lugemwa. A scholar is included among the top collaborators of Abbas Lugemwa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abbas Lugemwa. Abbas Lugemwa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
#WorkIndexed citations
1 5
2 14
3 21
4 2
5 27

About Abbas Lugemwa

Abbas Lugemwa is a scholar working on Virology, Infectious Diseases and Statistics and Probability, having authored 5 papers that have together received 69 indexed citations. Recurring topics across this work include HIV Research and Treatment (3 papers), HIV/AIDS drug development and treatment (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). The work is most often cited by research in Virology (32 citations), Infectious Diseases (42 citations) and Emergency Medicine (14 citations). Abbas Lugemwa has collaborated with scholars based in United Kingdom, Uganda and Zimbabwe. Frequent co-authors include Godfrey Musoro, Nicholas I. Paton, Diana M. Gibb, JA Thompson, Shafic Makumbi, Hellen Musana, Aggrey Mweemba, Carlo Giaquinto, Dickens Atwongyeire and David M. Burger. Their work appears in journals such as BMC Medical Research Methodology, Journal of NeuroVirology and Antiviral Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026